Lee Willis C

COO, DirectorEmmaus Life Sciences, Inc. (EMMA) · full profile →Form 4/A · filed Jan 3, 2024
Net Buying
Open-Market Buys
$15K
Open-Market Sells
$0
Net Open-Market Flow
$15K
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 30, 2023Buy(P)59K$0.12$7K395K
Nov 29, 2023Buy(P)36K$0.12$4K336K
Nov 28, 2023Buy(P)12K$0.12$1K300K
Nov 14, 2023Buy(P)1K$0.12$13244K
Aug 31, 2023Buy(P)6K$0.15$90043K
Aug 25, 2023Buy(P)7K$0.21$1K37K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001209191-24-000442) within minutes of acceptance. Every field above traces to the original document. Verify it directly: